MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cerebrospinal fluid measured α-synuclein is related to metabolite profile in the serum and CSF

K. Paul, D. Jones, B. Ritz (Los Angeles, USA)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein, Lipid metabolism

Category: Parkinson's Disease: Disease mechanisms

Objective: Determine metabolites associated with cerebrospinal fluid (CSF) measured α-synuclein (α-syn) using untargeted metabolomics measured in the serum and CSF.

Background: Several large studies have reported that α-syn levels in the CSF are lower among Parkinson’s disease (PD) patients relative to both controls and those with non-synucleinopathy neurodegenerative disease. This is likely due to the sequestration of α-syn into Lewy bodies among patients and CSF levels may be an indicator of increasing Lewy body pathology.

Method: We performed a metabolome-wide association study of CSF-measured α-syn (n=81, S4 study) using serum- and CSF-based untargeted metabolomics data derived from liquid chromatography with high-resolution mass spectrometry (LC-HRMS). We adjusted for PD severity, medication, and demographic variables.

Results: We identified 81 metabolite features associated with CSF α-syn at FDR<0.05 (30 CSF-measured metabolites and 51 serum-measured metabolites). Among the most statistically significantly associated metabolites were two metabolite features related to pirbuterol (adj-p>1.9e-08), lysyl-valine metabolites (adj-p>3.7e-04), citric acid (adj-p=2.1e-03), ceramide (adj-p=2.8e-03), and glucosylceramide (adj-p=7.3e-03), along with several likely PD medication and supplement-related metabolites, including progabide, benzothiazole, and n-acetylneuraminic acid. Overrepresented pathways among features associated in the CSF metabolome include glycine and serine metabolism, lysine metabolism, pentose and glucuronate interconversions, and sphingolipid metabolism. Pathways overrepresented in the serum metabolome included glycosphingolipid metabolism, androgen and estrogen metabolism, and c21-steroid hormone biosynthesis and metabolism.

Conclusion: The current study links a range of metabolic features and pathways to CSF-measured α-syn among PD patients. Among other pathways, this research further highlights ceramide and bioactive sphingolipid metabolism in PD and specifically in the accumulation of α-synuclein and formation of Lewy bodies.

To cite this abstract in AMA style:

K. Paul, D. Jones, B. Ritz. Cerebrospinal fluid measured α-synuclein is related to metabolite profile in the serum and CSF [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/cerebrospinal-fluid-measured-%ce%b1-synuclein-is-related-to-metabolite-profile-in-the-serum-and-csf/. Accessed October 6, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cerebrospinal-fluid-measured-%ce%b1-synuclein-is-related-to-metabolite-profile-in-the-serum-and-csf/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley